|
|
Found results for
 patents
1.
|
PRODUCTION OF HIGHLY PURIFIED 212PB
| Application Number |
19076415 |
| Status |
Pending |
| Filing Date |
2025-03-11 |
| First Publication Date |
2025-06-26 |
| Owner |
Sciencons AS (Norway)
|
| Inventor |
Larsen, Roy H.
|
Abstract
The present invention relates to assemblies and method for obtaining a container comprising 212Pb on the walls obtained from a 212Pb precursor isotope source. The invention provides an improved system and method for producing 212Pb in high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.
IPC Classes ?
- G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
- G21F 5/015 - Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation unitsRadioisotope containers
- G21F 5/018 - Syringe shields or holders
|
2.
|
PRODUCTION OF HIGHLY PURIFIED 212PB
| Application Number |
18940734 |
| Status |
Pending |
| Filing Date |
2024-11-07 |
| First Publication Date |
2025-06-26 |
| Owner |
Sciencons AS (Norway)
|
| Inventor |
Larsen, Roy H.
|
Abstract
The present invention relates to assemblies and method for obtaining a container comprising 212Pb on the walls obtained from a 212Pb precursor isotope source. The invention provides an improved system and method for producing 212Pb in high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.
IPC Classes ?
- G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
- G21F 5/015 - Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation unitsRadioisotope containers
- G21F 5/018 - Syringe shields or holders
|
3.
|
Production Of Highly Purified 212PB
| Application Number |
18940751 |
| Status |
Pending |
| Filing Date |
2024-11-07 |
| First Publication Date |
2025-06-26 |
| Owner |
Sciencons AS (Norway)
|
| Inventor |
Larsen, Roy H.
|
Abstract
The present invention relates to assemblies and method for obtaining a container comprising 212Pb on the walls obtained from a 212Pb precursor isotope source. The invention provides an improved system and method for producing 212Pb in high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.
IPC Classes ?
- G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
- G21F 5/015 - Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation unitsRadioisotope containers
- G21F 5/018 - Syringe shields or holders
|
4.
|
Production of Highly Purified 212PB
| Application Number |
18940735 |
| Status |
Pending |
| Filing Date |
2024-11-07 |
| First Publication Date |
2025-06-19 |
| Owner |
Sciencons AS (Norway)
|
| Inventor |
Larsen, Roy H.
|
Abstract
The present invention relates to assemblies and method for obtaining a container comprising 212Pb on the walls obtained from a 212Pb precursor isotope source. The invention provides an improved system and method for producing 212Pb in high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.
IPC Classes ?
- G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
- G21F 5/015 - Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation unitsRadioisotope containers
- G21F 5/018 - Syringe shields or holders
|
5.
|
COMPLEXES FOR CANCER TREATMENT AND IMAGING
| Application Number |
18729758 |
| Status |
Pending |
| Filing Date |
2023-01-20 |
| First Publication Date |
2025-03-27 |
| Owner |
SCIENCONS AS (Norway)
|
| Inventor |
Larsen, Roy H.
|
Abstract
The present invention relates to complexes comprising a PSMA targeting compound linked to a radionuclide such as 47Sc, 111In, 161Tb. These compounds, and pharmaceutical compositions comprising them, can be used for medical applications, including in the treatment of cancer as well as in monitoring and diagnostics.
|
6.
|
Production of highly purified 212PB
| Application Number |
18942340 |
| Grant Number |
12394533 |
| Status |
In Force |
| Filing Date |
2024-11-08 |
| First Publication Date |
2025-02-27 |
| Grant Date |
2025-08-19 |
| Owner |
SCIENCONS AS (Norway)
|
| Inventor |
Larsen, Roy H.
|
Abstract
The present invention relates to assemblies and method for obtaining a container comprising 212Pb on the walls obtained from a 212Pb precursor isotope source. The invention provides an improved system and method for producing 212Pb in high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.
IPC Classes ?
- G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
- G21F 5/015 - Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation unitsRadioisotope containers
- G21F 5/018 - Syringe shields or holders
|
7.
|
Production of highly purified 212PB
| Application Number |
18680605 |
| Grant Number |
12249437 |
| Status |
In Force |
| Filing Date |
2024-05-31 |
| First Publication Date |
2024-11-28 |
| Grant Date |
2025-03-11 |
| Owner |
Sciencons AS (Norway)
|
| Inventor |
Larsen, Roy H.
|
Abstract
212Pb in high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.
IPC Classes ?
- G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
- G21F 5/015 - Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation unitsRadioisotope containers
- G21F 5/018 - Syringe shields or holders
|
8.
|
PRODUCTION OF HIGHLY PURIFIED 212PB
| Application Number |
18680372 |
| Status |
Pending |
| Filing Date |
2024-05-31 |
| First Publication Date |
2024-10-03 |
| Owner |
Sciencons AS (Norway)
|
| Inventor |
Larsen, Roy H.
|
Abstract
The present invention relates to assemblies and method for obtaining a container comprising 212Pb on the walls obtained from a 212Pb precursor isotope source. The invention provides an improved system and method for producing 212Pb in high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.
IPC Classes ?
- G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
- G21F 5/015 - Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation unitsRadioisotope containers
- G21F 5/018 - Syringe shields or holders
|
9.
|
COMPLEX COMPRISING A PSMA-TARGETING COMPOUND LINKED TO A LEAD OR THORIUM RADIONUCLIDE
| Application Number |
18628420 |
| Status |
Pending |
| Filing Date |
2024-04-05 |
| First Publication Date |
2024-07-25 |
| Owner |
Sciencons AS (Norway)
|
| Inventor |
Larsen, Roy Hartvig
|
Abstract
The present invention relates to complexes comprising a prostate-specific membrane antigen (PSMA) targeting compound linked to a radionuclide, such as 212Pb or 227Th, through a TCMC or DOTA chelating moiety. These compounds, and pharmaceutical compositions comprising them, can be used for medical applications. These applications include the treatment of prostate cancer, and the complexes allow for dual targeting of cancers.
IPC Classes ?
- C07F 7/24 - Lead compounds
- A61K 51/04 - Organic compounds
- A61P 35/00 - Antineoplastic agents
- A61P 35/04 - Antineoplastic agents specific for metastasis
- C07B 59/00 - Introduction of isotopes of elements into organic compounds
- C07F 3/00 - Compounds containing elements of Groups 2 or 12 of the Periodic Table
- C07F 9/94 - Bismuth compounds
|
10.
|
Complex comprising a PSMA-targeting compound linked to a lead or thorium radionuclide
| Application Number |
18505688 |
| Grant Number |
12297218 |
| Status |
In Force |
| Filing Date |
2023-11-09 |
| First Publication Date |
2024-06-06 |
| Grant Date |
2025-05-13 |
| Owner |
SCIENCONS AS (Norway)
|
| Inventor |
Larsen, Roy Hartvig
|
Abstract
The present invention relates to complexes comprising a prostate-specific membrane antigen (PSMA) targeting compound linked to a radionuclide, such as 212Pb or 227Th, through a TCMC or DOTA chelating moiety. These compounds, and pharmaceutical compositions comprising them, can be used for medical applications. These applications include the treatment of prostate cancer, and the complexes allow for dual targeting of cancers.
IPC Classes ?
- C07F 7/24 - Lead compounds
- A61K 51/04 - Organic compounds
- A61P 35/00 - Antineoplastic agents
- A61P 35/04 - Antineoplastic agents specific for metastasis
- C07B 59/00 - Introduction of isotopes of elements into organic compounds
- C07F 3/00 - Compounds containing elements of Groups 2 or 12 of the Periodic Table
- C07F 9/94 - Bismuth compounds
|
11.
|
COMPLEXES FOR CANCER TREATMENT AND IMAGING
| Application Number |
EP2023051355 |
| Publication Number |
2023/139203 |
| Status |
In Force |
| Filing Date |
2023-01-20 |
| Publication Date |
2023-07-27 |
| Owner |
SCIENCONS AS (Norway)
|
| Inventor |
Larsen, Roy H.
|
Abstract
The present invention relates to complexes comprising a PSMA targeting compound linked to a radionuclide such as 47Sc, 111In, 161Tb. These compounds, and pharmaceutical compositions comprising them, can be used for medical applications, including in the treatment of cancer as well as in monitoring and diagnostics.
|
12.
|
212Pb
| Application Number |
17756802 |
| Grant Number |
12125603 |
| Status |
In Force |
| Filing Date |
2020-12-04 |
| First Publication Date |
2023-01-19 |
| Grant Date |
2024-10-22 |
| Owner |
Sciencons AS (Norway)
|
| Inventor |
Larsen, Roy H.
|
Abstract
212Pb high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.
IPC Classes ?
- G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
- G21F 5/015 - Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation unitsRadioisotope containers
- G21F 5/018 - Syringe shields or holders
|
13.
|
PRODUCTION OF HIGHLY PURIFIED 212PB
| Application Number |
EP2020084701 |
| Publication Number |
2021/110950 |
| Status |
In Force |
| Filing Date |
2020-12-04 |
| Publication Date |
2021-06-10 |
| Owner |
SCIENCONS AS (Norway)
|
| Inventor |
Larsen, Roy, H.
|
Abstract
The present invention relates to assemblies and method for obtaining a container comprising212Pb on the walls obtained from a212Pb precursor isotope source. The invention provides an improved system and method for producing212Pb in high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.
IPC Classes ?
- G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
- A61K 51/12 - Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes
|
14.
|
212Pb labeled monoclonal antibodies
| Application Number |
16307811 |
| Grant Number |
11306038 |
| Status |
In Force |
| Filing Date |
2017-06-23 |
| First Publication Date |
2019-06-27 |
| Grant Date |
2022-04-19 |
| Owner |
SCIENCONS AS (Norway)
|
| Inventor |
Larsen, Roy Hartvig
|
Abstract
The present invention relates to the generation of lead-212 for therapeutic use. Specifically, are methods related to the generation of lead-212 based radio labelled proteins, such as radioimmunoconjugates, embodiments of the present invention.
IPC Classes ?
- A61K 51/00 - Preparations containing radioactive substances for use in therapy or testing in vivo
- A61M 36/14 - Radioactive dressings
- C07B 59/00 - Introduction of isotopes of elements into organic compounds
- A61K 51/10 - Antibodies or immunoglobulinsFragments thereof
|
15.
|
COMPLEX COMPRISING A PSMA-TARGETING COMPOUND LINKED TO A LEAD OR THORIUM RADIONUCLIDE
| Application Number |
EP2018084738 |
| Publication Number |
2019/115684 |
| Status |
In Force |
| Filing Date |
2018-12-13 |
| Publication Date |
2019-06-20 |
| Owner |
SCIENCONS AS (Norway)
|
| Inventor |
Larsen, Roy Hartvig
|
Abstract
The present invention relates to complexes comprising a prostate- specific membrane antigen (PSMA) targeting compound linked to a radionuclide, such as 212Pb or 227Th, through a TCMC or DOTA chelating moiety. These compounds, and pharmaceutical compositions comprising them, can be used for medical applications. These applications include the treatment of prostate cancer, and the complexes allow for dual targeting of cancers.
|
16.
|
Lead and thorium compounds
| Application Number |
16219072 |
| Grant Number |
10377778 |
| Status |
In Force |
| Filing Date |
2018-12-13 |
| First Publication Date |
2019-06-13 |
| Grant Date |
2019-08-13 |
| Owner |
Sciencons AS (Norway)
|
| Inventor |
Larsen, Roy Hartvig
|
Abstract
227Th. These compounds, and pharmaceutical compositions comprising them, can be used for medical applications. These applications include the treatment of prostate cancer, and the complexes allow for dual targeting of cancers.
IPC Classes ?
- C07F 7/24 - Lead compounds
- C07F 3/00 - Compounds containing elements of Groups 2 or 12 of the Periodic Table
- C07F 9/94 - Bismuth compounds
- A61P 35/04 - Antineoplastic agents specific for metastasis
- C07B 59/00 - Introduction of isotopes of elements into organic compounds
- A61K 51/04 - Organic compounds
- A61P 35/00 - Antineoplastic agents
|
17.
|
Radiopharmaceutical solutions with advantageous properties
| Application Number |
15553298 |
| Grant Number |
10434198 |
| Status |
In Force |
| Filing Date |
2016-02-24 |
| First Publication Date |
2018-02-01 |
| Grant Date |
2019-10-08 |
| Owner |
Sciencons AS (Norway)
|
| Inventor |
Larsen, Roy Hartvig
|
Abstract
224Ra based solutions for medial treatments.
IPC Classes ?
- A61K 51/10 - Antibodies or immunoglobulinsFragments thereof
- A61K 51/02 - Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier
- A61K 51/04 - Organic compounds
- A61K 51/12 - Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes
|
18.
|
PREPARATION OF 212PB LABELED MONOCLONAL ANTIBODIES
| Application Number |
EP2017065508 |
| Publication Number |
2017/220767 |
| Status |
In Force |
| Filing Date |
2017-06-23 |
| Publication Date |
2017-12-28 |
| Owner |
SCIENCONS AS (Norway)
|
| Inventor |
Larsen, Roy Hartvig
|
Abstract
The present invention relates to the generation of lead-212 for therapeutic use. Specifically, are methods related to the generation of lead-212 based radio labelled proteins, such as radioimmunoconjugates, embodiments of the present invention.
IPC Classes ?
- A61K 51/10 - Antibodies or immunoglobulinsFragments thereof
|
19.
|
RADIOPHARMACEUTICAL SOLUTIONS WITH ADVANTAGEOUS PROPERTIES
| Application Number |
EP2016053874 |
| Publication Number |
2016/135200 |
| Status |
In Force |
| Filing Date |
2016-02-24 |
| Publication Date |
2016-09-01 |
| Owner |
SCIENCONS AS (Norway)
|
| Inventor |
Larsen, Roy, Hartvig
|
Abstract
The present invention relates to radiopharmaceutical compositions comprising the mother nuclide 224Ra, its daughter nuclide 212Pb, and a complexing agent that complexes with the daughter nuclide. The use of targeted chelate scavengers for 224Ra daughter nuclide opens up the possibility for using 224Ra based solutions for medical treatments.
|
20.
|
Radiopharmaceutical solutions with advantageous properties
| Application Number |
14632849 |
| Grant Number |
09433690 |
| Status |
In Force |
| Filing Date |
2015-02-26 |
| First Publication Date |
2016-09-01 |
| Grant Date |
2016-09-06 |
| Owner |
SCIENCONS AS (Norway)
|
| Inventor |
Larsen, Roy Hartvig
|
Abstract
224Ra based solutions for medical treatments.
IPC Classes ?
- A61K 51/00 - Preparations containing radioactive substances for use in therapy or testing in vivo
- A61M 36/14 - Radioactive dressings
- A61K 51/10 - Antibodies or immunoglobulinsFragments thereof
|
21.
|
RADIOPHARMACEUTICAL SOLUTIONS WITH ADVANTAGEOUS PROPERTIES
| Document Number |
02973644 |
| Status |
In Force |
| Filing Date |
2016-02-24 |
| Grant Date |
2023-09-19 |
| Owner |
SCIENCONS AS (Norway)
|
| Inventor |
Larsen, Roy Hartvig
|
Abstract
The present invention relates to radiopharmaceutical
compositions comprising the mother nuclide 224Ra, its daughter
nuclide 212Pb, and a complexing agent that complexes with the daughter
nuclide. The use of targeted chelate scavengers for 224Ra daughter
nuclide opens up the possibility for using 224Ra based solutions for
medical treatments.
|
22.
|
PREPARATION OF 212PB LABELED MONOCLONAL ANTIBODIES
| Document Number |
03026599 |
| Status |
Pending |
| Filing Date |
2017-06-23 |
| Owner |
SCIENCONS AS (Norway)
|
| Inventor |
Larsen, Roy Hartvig
|
Abstract
The present invention relates to the generation of lead-212 for therapeutic use. Specifically, are methods related to the generation of lead-212 based radio labelled proteins, such as radioimmunoconjugates, embodiments of the present invention.
IPC Classes ?
- A61K 51/10 - Antibodies or immunoglobulinsFragments thereof
|
23.
|
COMPLEX COMPRISING A PSMA-TARGETING COMPOUND LINKED TO A LEAD OR THORIUM RADIONUCLIDE
| Document Number |
03085205 |
| Status |
Pending |
| Filing Date |
2018-12-13 |
| Owner |
SCIENCONS AS (Norway)
|
| Inventor |
Larsen, Roy Hartvig
|
Abstract
The present invention relates to complexes comprising a prostate- specific membrane antigen (PSMA) targeting compound linked to a radionuclide, such as 212Pb or 227Th, through a TCMC or DOTA chelating moiety. These compounds, and pharmaceutical compositions comprising them, can be used for medical applications. These applications include the treatment of prostate cancer, and the complexes allow for dual targeting of cancers.
IPC Classes ?
- A61K 51/04 - Organic compounds
- A61P 35/00 - Antineoplastic agents
- A61P 35/04 - Antineoplastic agents specific for metastasis
- C07D 257/02 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
|
24.
|
PRODUCTION OF HIGHLY PURIFIED 212PB
| Document Number |
03160031 |
| Status |
Pending |
| Filing Date |
2020-12-04 |
| Owner |
SCIENCONS AS (Norway)
|
| Inventor |
Larsen, Roy H.
|
Abstract
The present invention relates to assemblies and method for obtaining a container comprising212Pb on the walls obtained from a212Pb precursor isotope source. The invention provides an improved system and method for producing212Pb in high purity without the need for processing, with high yields, and which safely and efficiently can be transported to the locations where it is to be used.
IPC Classes ?
- A61K 51/12 - Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes
- G21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes
|
|
